Scientific Communications: SVD and cogniton 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.01 - PREVENTION O - ESOC25-2242 INVESTIGATING THE ASSOCIATION OF A BRAIN CARE SCORE WITH STRUCTURAL BRAIN CHANGES AND COGNITIVE IMPAIRMENT Jenna Schellin 1 , Susanne Sehner 1 , Marie Neumann 1 , Marvin Petersen 1 , Felix Ngele 1 , Sanjula Singh 2,3,4,5 , Jonathan Rosand 2,3,4,5 , Nils Schumacher 6 , Birgit-Christiane Zyriax 1 , Raphael Twerenbold 1 , Bastian Cheng 1 , Gtz Thomalla, Mrit Jensen 1 1 University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 2 Broad Institute of MIT and Harvard, Cambridge, MA, United States, Boston, United States, 3 Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, United States, 4 Center for Genomic Medicine, Massachusetts General Hospital, Boston, United States, 5 Department of Neurology, Massachusetts General Hospital, Boston, United States, 6 Faculty of Psychology and Human Movement, Institute of Human Movement Science, University of Hamburg, Hamburg, Germany Background and Aims: The Brain Care Score (BCS) aims to encourage patients to change their behavior in order to modify risk factors and prevent dementia
Blue Helix Health #longevity #NMN #DietarySupplements #Nutraceuticals #HealthyAging #RegulatoryUpdate FDA has responded to citizen petitions from Natural Products Association Alliance for Natural Health USA and Council for Responsible Nutrition, reversing its position that #NMN is not a dietary ingredient, and revising how it interprets the drug preclusion clause in certain ways
Research published in Dermatologic Surgery demonstrated that subcutaneous delivery of bioactive peptides produced dermal tissue concentrations 4.2 higher than IM administration at 24 hours post-injection, with sustained elevation lasting 72+ hours
In the field, A
Endocrine, Metabolic & Immune Disorders Drug Targets , vol
Many in Australia use it to manage nerve health and fatigue
